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Caenorhabditis elegans is a free-living nematode that resides in soil and typically feeds on bacteria. 
We postulate that haematophagic C. elegans could provide a model to evaluate vaccine responses to 
intestinal proteins from hematophagous nematode parasites, such as Necator americanus. Human 
erythrocytes, fluorescently labelled with tetramethylrhodamine succinimidyl ester, demonstrated a 
stable bright emission and facilitated visualization of feeding events with fluorescent microscopy. C. 
elegans were observed feeding on erythrocytes and were shown to rupture red blood cells upon 
capture to release and ingest their contents. In addition, C. elegans survived equally on a diet of 
erythrocytes. There was no statistically significant difference in survival when compared with a diet of 
Escherichia coli OP50. The enzymes responsible for the digestion and detoxification of haem and 
haemoglobin, which are key components of the hookworm vaccine, were found in the C. elegans 
intestine. These findings support our postulate that free-living nematodes could provide a model for 
the assessment of neutralizing antibodies to current and future hematophagous parasite vaccine 
candidates. 
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‘The blood is the life!’ Dracula (Stoker, 1897)  
 
Caenorhabditis elegans is a nonparasitic free-living nematode (Sulston, 1976). It has become a 
powerful tool to model complex biological processes in genetics (Brenner, 1974), neurology (Chalfie 
et al., 1994) and cell survival (Adams and Cory, 1998), due to its relative ease of growth and 
maintenance (Stiernagle, 2006). More recently, C. elegans has been identified as a suitable model to 
study parasitic behaviour (Crisford et al., 2013) and facilitate the discovery of anthelmintic drugs 
(Burns et al., 2015).  
 
Parasites infect a quarter of the global population (Bethony et al., 2006). Infections have a negative 
impact on human health and productivity (Keiser and Utzinger, 2010) as well as economic output, due 
to the infection of crops (Fuller et al., 2008) and livestock (Besier, 2007). Bearing this in mind 
international initiatives, such as the Human Hookworm Vaccine Initiative targeted against Necator 
americanus (Sabin Vaccine Institute, 2014), have been established to develop and test vaccines to 
prevent infection of humans. The complex life-cycles of parasitic nematodes, which rely on a host for 
propagation (Chauhan et al., 2017), may serve as a barrier to the development of therapeutics to 
prevent and treat infections (Holden-Dye and Walker, 2007). Therefore, C. elegans, which has an easily 
maintained lifecycle (Lightfoot et al., 2016) that is independent of host interaction, may provide an 
alternative model to study parasitic infections.  
 
In the present study, we investigated if C. elegans could ingest and then survive on a diet of human 
erythrocytes. These experiments were performed as a prelude to nominating a hematophagous C. 
elegans as a model to further understand haem metabolism in nematodes, coupled with the 
interrogation of immune responses to vaccines currently under development, and to identify new 
vaccine candidate molecules involved in the intestinal biochemical pathways of hematophagous 
nematodes.  
 
Aspartic proteinases (APRs) and glutathione-S-transferase (GST) have assumed prominence in vaccine 
development due to their ability to digest haemoglobin and neutralize the toxic by-products of 
haemoglobin digestion, respectively. In this context, the current vaccine under development to 
combat necatoriasis is bivalent (Hotez et al., 2010), comprising of an aspartic haemoglobinase (Na-
APR-1) and a GST (Na-GST-1) (Brophy and Pritchard, 1992; Brown et al., 1995; Williamson et al., 2002). 
These enzymes function in tandem in the hookworm gut to process human haemoglobin then detoxify 
haem. Furthermore, neutralizing antibodies raised to the hookworm enzymes have been linked to the 
protective capacity of the Na-APR-1 component of the vaccine, indicating that sequence identity 
around the active sites and other epitopic regions of the C. elegans and N. americanus enzymes could 
be of immunological relevance (Pearson et al., 2010). Therefore, the demonstration of hematophagy 
in C. elegans would pave the way for unambiguous experiments to test the modes of action of these 
neutralizing antibodies and to search for new gastrointestinal tract associated vaccine candidates.  
 
In order to observe the haematophagic C. elegans, erythrocytes were harvested from a human blood 
donor. Erythrocytes were labelled with the fluorophores [caboxyfluorescein succinimidyl ester (FAM-
SE), fluorescein isothiocyanate (FITC) and tetramethylrhodamine succinimidyl ester (TAMRA-SE)] to 
facilitate the visualization of erythrocyte ingestion and digestion. The viability of C. elegans fed on 
erythrocytes alone, when compared with nematodes fed on E. coli alone and a mixture of erythrocytes 
and E. coli, was monitored as a function or their motility. Furthermore, databases were screened to 
identify if C. elegans, like the parasitic N. americanus, translated proteins capable of the enzymatic 
processing of haemoglobin. 
 




C. elegans Bristol N2 and E. coli OP50 were purchased from Caenorhabditis Genetics Center (CGC). 
Agar, protease peptone, cholesterol, gentamicin sulphate, EDTA, Alsever’s, Dulbecco’s and sodium 
hypochlorite solutions were obtained from Sigma-Aldrich (Gillingham,UK). Fluorescein isothiocyanate, 
carboxyfluorescein-SE, TAMRA-SE and BD Vacutainer® blood collection tubes were obtained from 
Thermo-Fisher- Scientific (Loughborough, UK). Blood was donated by DIP (blood group B Rh negative). 
Deionized water (18.2 MΩ) was generated by Elga Purelab Ultra (ULXXXGEM2). 
 
Methods  
Blood collection  
BD Vacutainer® tubes containing ethylenediaminetetraacetic acid (EDTA) (1.8 mg mL−1 of blood) were 
used to collect blood from a healthy volunteer (4.5 mL). Initially, centrifugation was used to separate 
erythrocytes from plasma and leucocytes (800 rpm, 8 min). Erythrocytes were resuspended and 
washed a further 3 times in Alsever’s solution using centrifugation (800 rpm, 8 min); discarding the 
supernatant, containing plasma and EDTA, and any remaining leucocytes and after each wash. After 
the final wash, the pellet was made up to 10 mL with Alsever’s solution (∼ 6 × 108 cells mL−1) and 
stored at 4 °C.  
 
Establishing erythrocyte concentrations  
Aliquots of the stock solution (10 µL) were serially diluted with Alsever’s solution (90 µL), to create 
solutions at concentrations 6 × 108, 6 × 107, 6 × 106, 6 × 105, 6 × 104, 6 × 103, 6 × 102 6 × 101 and 6 × 100 
cells mL−1. Microscopy was used to determine a cell density that would permit free imaging of both 
erythrocytes and C. elegans.  
 
Fluorescent labelling of erythrocytes  
Erythrocytes (500 µL, 3 × 108 cells mL−1) were added to fluorescein isothiocyanate, carboxyfluorescein-
SE or TAMRA-SE in Dulbecco’s phosphate buffered saline solution (1 mg mL−1, 500 µL, pH 8.0) and 
delicately inverted [2h, 1 rpm, HulaMixer™ (Invitrogen), 4 °C]. Erythrocytes were washed with 
Dulbecco’s solution (15 × times, 10 mL−1) and collected with centrifugation (800 rpm, 8 min). Labelling 
was confirmed with fluorescence microscopy using a Nikon Eclipse TE300 equipped with a Plan Fluor 
40 × 0.75 NA objective and CoolLED pE-4000 and pE-100 light source. Labelled erythrocytes were 
suspended in Alsever’s solution and stored in a light protected container at 4 °C.  
 
Signal-to-noise ratio  
The signal-to-noise ratio for erythrocytes was determined by drawing a line profile at the centre of 
erythrocytes labelled with either FAM-SE, FITC and TAMRA-SE. A Nikon Eclipse T1 and QIMAGING 
optiMOS camera equipped with CoolLED pE-4000 fluorescence illumination and pE-100 bright field 
illumination and 10 × (0.30 NA) objectives were used to image samples. Fluorescence was captured 
through excitation at 490 nm and 540 nm collecting at emission between 519 ± 26 nm 595 ± 33 nm 
(Exposure times 100 µs, LED power 50%). Images were analysed with FIJI open source software. 
 
Growth and maintenance 
Caenorhabditis elegans were maintained on NGM agar and Escherichia coli (OP50) at 20 °C. 
Synchronized growth cycles of C. elegans were prepared by harvesting eggs from gravid nematodes 
(Stiernagle, 2006). Briefly, high numbers of gravid nematodes were collected by rinsing NGM agar 
plates with ultra-pure sterile deionized water (4 mL). Sodium hydroxide (5 M, 0.5 mL) and sodium 
hypochlorite (5%, 1 mL) was added to the nematode suspension and vortexed (10 min) to release eggs 
and eliminate bacterial traces. The eggs were pelleted using centrifugation (1500 rpm, 1 min) and the 
supernatant discarded. The eggs were washed with ultra-pure sterile deionized water and collected 
using centrifugation (1500 rpm, 1 min). The egg suspensions were aspirated to 0.1 mL and C. elegans 
Page 5 of 15 
 
and were plated on freshly prepared NGM agar seeded with an E. coli lawn and incubated at 20 °C. 
The generation time of C. elegans under these conditions was 4–5 days. 
 
Dosing C. elegans with erythrocytes 
Synchronized nematodes were collected by washing NGM plates with sterile deionized water. C. 
elegans were washed in deionized water (10 mL) and collected using centrifugation (3 times, 1500 
rpm, 1 min). Nematodes were re-suspended in gentamicin (500 µg mL−1, 10 mL, 30 min) to remove 
traces of E. coli. C. elegans were washed again in sterile deionized water (10 mL) and collected using 
centrifugation to remove traces of gentamicin (3 times, 1500 rpm, 1 min). Pelleted C. elegans were 
added to fluorescently labelled erythrocytes (1 × 106 cells mL−1, TAMRA). Observations of erythrocyte 
ingestion were made using fluorescence microscopy using AMG F1 Microscope equipped with an AMG 
Plan Fluor 10 × 1.2 NA objective and Epiphan DVI2USB 3.0 (30 fps, 1920 × 1200 pixels) to capture 
video. Aliquots of nematode and blood suspending media (10 µL) were added to sterile tryptone soya 
broth media and incubated overnight to check for microbial contamination. 
 
Motility fraction half-life (Mft50) derivation 
To help describe the viability of nematode populations, using motility of nematode population as an 
indicator, the Mft50, the time required to reduce the motility of population of nematodes by 50%, was 
derived for C. elegans treated with (1) erythrocytes, (2) E. coli, and (3) erythrocytes and E. coli. For 
each data point, 100 nematodes were evaluated in triplicate and the standard deviation was 
calculated. Statistical analyses were conducted using Student’s t-test, where P < 0.05 indicated 
statistical significance. 
 
Protein sequence analysis 
The known sequences for N. americanus aspartic haemoglobinase (Necepsin II/Na-APR-1, Uniprot 
Q9N9H3) and GST (Na-GST-1, Uniprot D3U1A5) were searched on UniProt for sequence identity in C. 
elegans. Sequences were aligned using the National Institute for Health’s National Center for 
Biotechnology Information blastp tool. The sequences were annotated, where available, with respect 




Fluorescent labelling of erythrocytes 
In order to observe the haematophagic C. elegans, erythrocytes were harvested from a human blood 
donor. Erythrocytes were separated from whole blood by centrifugation, using EDTA as an 
anticoagulant and stored in Alsever’s solution, to enable preservation and long-term storage of 
erythrocytes (Li et al., 2007). C. elegans and erythrocytes, when visualized using a brightfield 
microscope, are optically transparent, such that only refracted light, due the curvature of the 
nematode anatomy and torus geometry of the red blood cell, permits their visualization. Therefore, 
to enhance the contrast between C. elegans and erythrocytes and to augment visualization of 
hematophagy events using fluorescence microscopy, red blood cells were fluorescently labelled with 
either FAM-SE, FITC or TAMRA-SE. Succinimidyl esters and isothiocyanates readily conjugate to 
biological protein rich structures that contain amine functional groups, typically found in lysine 
residues, via stable carboxyamide and thiourea bonds, respectively (Haugland, 2005). 
 
FAM-SE, FITC and TAMRA-SE were all able to label erythrocytes (Fig. S1). TAMRA-SE demonstrated 
highly effective labelling of erythrocytes, Fig. 1A. This is because TAMRA-SE labelled erythrocytes, 
when subjected to the same excitation power and exposure time for imaging, demonstrated, 1.6 × 
and 6.7 × greater signal to noise ratio, when compared with FAM-SE and FITC labelled erythrocytes, 
respectively (Fig. 1B). These observations could be attributed to a combination of factors, which 
include greater labelling efficiency and stability of succinimidyl esters, when compared with 
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isothiocyanates (Banks and Paquette, 1995), and the superior quantum yield of TAMRA-SE in 
comparison with FAM-SE and FITC (Haugland, 2005). Furthermore, the utility of TAMRA-SE labelled 
erythrocytes permits imaging of C. elegans in the absence of unwanted substantial age-related green 
lipofuscin auto-fluorescence (Forge and Macguidwin, 1986; Pincus et al., 2016) (Fig. 1C) and unwanted 
blue excitation light dependent phototaxis (Ward et al., 2008), thus augmenting imagining capabilities 
of haematophagic events. This is because lipofuscin auto-fluorescence could generate unwanted 
imaging artefacts that could be interpreted as internalized erythrocytes. In addition, blue light, which 
is used to excite FAM-SE and FITC fluorescence emission, initiates heightened light dependent C. 
elegans motility that renders continual high frame imaging of haematophagic events challenging. 
 
Observation of haematophagic events 
To permit effective visualization of red blood cells and nematodes in a single field of view, erythrocyte 
counts were performed by serially diluting the stock solution. A concentration of 1 × 106 cells mL−1 was 
identified as a concentration that would enable observation of hematophagy events using 
fluorescence microscopy. 
 
The occurrence of hematophagy was confirmed by feeding erythrocytes to axenic C. elegans for up to 
24 h. Internalized erythrocytes were visualized in the pharynx and intestinal tract of nematodes after 
5 h, Fig. 2. After 24 h, virtually all red blood cells had been consumed. From our observations, all stages 
of C. elegans were able to consume erythrocytes, but the labelling of the intestinal tract was limited 
to a select number of nematodes. 
 
The diameter of an erythrocyte (∼10 µM, Fig. 1B) is approximately twice the diameter of an adult C. 
elegans mouth opening [∼3–4 µM (Altun and Hall, 2018)] and more than 3 times the size of E.coli 
[∼2–3 µM (Reshes et al., 2008)], such that during feeding C. elegans could be unable to ingest whole 
red blood cells. Therefore, to decipher the mechanism of erythrocyte ingestion nematodes were 
continually imaged using fluorescence microscopy (see Supporting Movie 1). Time-lapse images (Fig. 
3) show the ingestion of erythrocytes by C. elegans that occurs via a 5-step process: (1) C. elegans 
survey their immediate vicinity for sustenance (1.35 s). These observations highlight that C. elegans 
are capable of adapting, by modifying their mechanism of food ingestion, rather than limiting their 
diet to smaller bacterial organisms (Fang-Yen et al., 2009). 
 
The loss of erythrocyte integrity visualized during C. elegans digestion (Fig. 3, Supporting Movie 1) 
would release haemoglobin, which is toxic to organisms upon the release of haem. Therefore, to cope 
with potential haem toxicity, nematodes use enzymatic pathways that include APRs and GSTs to 
neutralize the toxic by-products of haemoglobin digestion (Perally et al., 2008). 
 
Viability of C. elegans during erythrocyte feeding 
 
The motility of C. elegans can be used to predict viability as nematode body movement gradually 
declines and stops completely with age (Collins et al., 2008). Using C. elegans motility as an absolute 
parameter, where motile and non-motile nematodes were classified as viable and non-viable the 
effects of restricting the nematode diet to erythrocytes alone, E. coli alone or a mixture of erythrocytes 
and E. coli was investigated. The motility fraction (Mf), as an indicator for C. elegans viability (Chauhan 
et al., 2013), showed the three diets did not affect the overall viability (Fig. 4, P > 0.05) and were 
comparable with previously reported survivorship data (Wood et al., 2004). 
 
To determine the effect of different diets on the viability of nematodes, the Mft50, the time required 
to reduce the motility of population of nematodes by 50%, was derived. The Mft50 for C. elegans fed 
on erythrocyte alone, E. coli alone and erythrocyte and E. coli were 7.07 (± 0.96 S.D.) days, 8.71 (± 0.13 
S.D.) days and 7.68 (± 0.57 S.D.) days, respectively, and were not statistically different (P > 0.05). 
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Therefore, under an erythrocyte diet was not affected when compared with the control groups of E. 
coli and erythrocytes and E. coli. 
 
Enzyme sequence identities between C. elegans and N. americanus 
A high degree of sequence identity was confirmed. In particular, peptide A291Y, an epitope in Na-APR-
1 (Necepsin II) recognized by enzyme neutralizing and host-protective antibodies, shares 71% identity 
and 10/13 active site amino acids with C. elegans Asp-4 (Fig. 5). The sequence identities between the 
respective GSTs are shown in Fig. S2. 
DISCUSSION 
The scientific community is keen to develop vaccines against parasitic nematodes of humans (Noon 
and Aroian, 2017) and livestock (Nisbet et al., 2016). During vaccine development, APRs have assumed 
prominence given their ability to digest haemoglobin. It is apparent that neutralizing antibodies that 
interfere with the activity of these enzymes contribute to host protection. High levels of sequence 
identity, between enzymes involved in hematophagy, have also been identified with Schistosoma 
mansoni, Onchocerca volvulus, Strongyloides stercoralis, Ancylostoma spp and Haemonchus 
contortus. Therefore, the development of a high-throughput model, using a nematode species that is 
simple to manipulate, to investigate parasite hematophagy could become a high priority for the 
parasitological research community (Buckingham and Sattelle, 2009). 
In the present paper, we have demonstrated that C. elegans were able to ingest and digest 
fluorescently labelled erythrocytes. Ingestion would appear to begin with erythrocyte rupture at the 
mouth and could be followed by mechanical degradation by the pharyngeal grinder (Avery and 
Thomas, 1997), with cell membrane rupture complemented by potential haemolysins, such as the C. 
elegans saponins and amoebapores (Banyai and Patthy, 1998), which are activated by a low pH 
microenvironment (McGhee, 2007). Haemoglobin digestion and haem detoxification could be 
conducted by C. elegans Aspartyl Protease 4 and GST. 
At this stage, we feel that sufficient initial evidence has been attained to support experiments to 
investigate antibodies raised against protein homologues from parasites, to assess their effects on the 
blood feeding and associated viability and survival of C. elegans. Proof of principle data on the value 
of the model would pave the way for the exploration of new targets associated with haem metabolism 
in nematodes (Chen et al., 2012; Sinclair and Hamza, 2015) and identify alternate gastrointestinal 
associated vaccine candidates 
With respect to candidate selection, gastrointestinal associated molecules with corresponding 
homologues in parasites would be selected, then cloned and expressed, enabling the production of 
mono-specific antibodies against the candidate molecule. The ability of this antibody to inhibit 
hematophagy by C. elegans, and have a negative impact on its survival, would be indicative of the 
value of the target molecule as a potential vaccine candidate. For example, the intestinally expressed 
lipases (Behm, 2002) the NUC-1 nuclease (Lyon et al., 2000), for processing cell free DNA from 
nucleated tissue cells and leucocytes, and calreticulin (CRT-1) could be considered as new vaccine 
candidates (Park et al., 2001; Winter et al., 2005). 
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In conclusion, Walker stated in 2005 that it was ‘difficult to disagree with the lament that 
unfortunately the biology of digestion (in C. elegans) represents something of a blind spot in this 
remarkably well-characterised organism’ (Walker et al., 2005). The conversion of C. elegans to 
hematophagy will hopefully promote new interest in the functioning of its intestine, where parallels 
may be drawn with the biochemistry of hematophagic parasites. 
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Fig. 1. (A) Brightfield, fluorescent red (TAMRA-SE) and merged images for TAMRA labelled red blood 
cells. (B) Cross-sectional intensity line plot across the centre of red blood cells labelled with 
carboxyfluorescein succinimidyl ester (FAM-SE), fluorescein isothiocyanate (FITC) and 
tetramethylrhodamine succinimidyl ester (TAMRA-SE). (Ci) Brightfield, (Cii) fluorescent red and (Ciii) 
merged image of C. elegans. Scale bars = 100 µm. 
  




Fig. 2. Brightfield, fluorescent (TAMRA-SE) and merged images for C. elegans feeding on fluorescently 
labelled (TAMRA-SE) red blood cells at 5 h and 24 h after red blood cell introduction. Scale bars = 100 
µm. 
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Fig. 3. Time-lapse images (0.00–1.35 s) for C. elegans ingesting fluorescently labelled red blood cells. 
For full-length video See Supporting Movie 1. Scale Bar = 100 µm. 
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Fig. 4. Motility fraction as an indicator of nematode survival for C. elegans fed on erythrocytes (red), 
E. coli alone (green) and erythrocytes & E. coli, monitored for 15 days. Each data point evaluates the 
motility of ∼100 nematodes each monitored in triplicate, where the error bars represent the standard 
deviation between experimental repeats. 
  




Fig. 5. (A) Search criteria and (B) amino acid overlay for C. elegans (C. ele, ASpartyl Protease 4, Query) 
and N. americanus (N. ame, Necepsin II, Subject). Highlighted regions indicate leader sequence (grey), 
Aspartic active sites (pink) and target epitopes [C. elegans (green), Overlay (77% match, yellow), N. 
americanus (red)]. 
